Why Choose Holden Comprehensive Cancer Center?

See Cancer Differently™

National Rankings Illustration

University of Iowa Holden Comprehensive Cancer Center is the only cancer center in Iowa designated as "comprehensive" by the National Cancer Institute and is ranked 18th by U.S. News & World Report (2018-19 rankings).

  • The National Accreditation Program for Breast Centers (NAPBC) awarded Holden a full three-year accreditation for its commitment to providing the highest quality of evaluation and management of patients diagnosed with breast disease (2016).
  • Holden received a national Outstanding Achievement Award from the Program Review Subcommittee of the Commission on Cancer (COC) for providing superior care to patients and families (2008).
  • CEO Cancer Gold Standard LogoHolden received the CEO Cancer Gold StandardTM accreditation, recognizing the center’s efforts to promote health and wellness for UI Health Care employees and their families. The award demonstrates the center’s responsibility to set a good example with a full range of employee wellness benefits such as tobacco-cessation programs, healthy food choices, early cancer detection coverage, and annual personal health assessments (2017).
  • American College of Surgeons Commission on Cancer granted approval to the Holden Comprehensive Cancer Center under a program designed to ensure quality cancer care for patients. This is a three-year accreditation (2013).
  • The Holden Comprehensive Cancer Center Adult and Pediatric Blood and Marrow Transplant (BMT) program has earned reaccreditation from the Foundation for the Accreditation of Cellular Therapy (FACT). FACT accreditation puts the University of Iowa BMT program on a select list of institutions that meet the most rigorous standards in every aspect of stem cell therapy, including clinical care, donor management, cell collection, processing, storage, transportation, administration, and cell release.
  • We were the first hospital in Iowa, and among the first medical centers nationwide, to participate in a large-scale preventive trial for prostate cancer.
  • We were the first hospital in the United States to offer a clinical trial of an adenovirus-prostate-specific antigen vaccine for prostate cancer patients (2000-present).
  • We were the first hospital in Iowa to use robotic surgery for radical prostatectomy procedures, in which a patient's cancerous prostate is removed.
  • We were the first hospital in Iowa to use robotic surgery for pyeloplasty procedures for treating patients with obstructed kidneys.
  • Our 4-D radiation therapy system increases odds of cancer survival.
  • 45,000 infusion therapy visits for cancer patients from July 2014 to June 2015.
  • 129,992 visits to UI Health Care with a primary diagnosis of cancer from July 2014 to June 2015.
  • 19,792 radiation oncology treatments delivered from July 2014 to June 2015.

Our Cancer Teams (M.O.G.s)


Cancer patients at the University of Iowa Holden Comprehensive Cancer Center (https://uihc.org/medical-services/holden-comprehensive-cancer-center) benefit from teams made up of cancer specialists and researchers who discuss the best treatment options for every patient, all while using the latest research findings. Mohammed Milhem, MBBS, medical oncologist, explains.

About Our New Cancer Clinic

A new cancer clinic and infusion suite at University of Iowa Hospitals & Clinics brings Holden Comprehensive Cancer Center physicians and researchers together and creates a more comfortable and efficient atmosphere for patients.

Support Our Mission

Our work is made possible in part by the support of donors through charitable giving. Friends of Holden Comprehensive Cancer Center can become partners in our efforts to control—and ultimately cure—cancer. Learn how you can help us make a difference for cancer patients.